U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07011771) titled 'A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease' on June 02.
Brief Summary: The goal of this clinical trial is to learn about the safety of CAP-003 gene therapy in adults with GBA1 associated Parkinson's Disease. It will also provide information about whether CAP-003 demonstrates efficacy in these adults.
Participants will have a single intravenous infusion of CAP-003 and visit the clinic regularly for 2 years for checkups and tests.
Study Start Date: Aug. 13
Study Type: INTERVENTIONAL
Condition:
GBA1 Parkinson Disease
Intervention:
DRUG: gene therapy
IV gene therapy
DRUG:...